Experiential Avoidance in Combat Veterans With and Without Posttraumatic Stress Disorder
NCT ID: NCT01652430
Last Updated: 2015-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
78 participants
OBSERVATIONAL
2010-10-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brief Cognitive Behavioral Therapy Replication Trial
NCT03769259
Written Exposure Therapy Versus Prolonged Exposure: a Non-inferiority Trial
NCT03962504
Improving Treatment Outcomes for Suicidal Veterans With PTSD
NCT04690582
Suicide and Trauma Reduction Initiative Among VEterans
NCT03933059
Self-Help Cognitive Processing Therapy (CPT)/Women Veterans Network (WoVeN) Study
NCT07250061
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PTSD cohort
No interventions assigned to this group
No PTSD cohort
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Diagnosis of PTSD confirmed by the CAPS or
3. No current diagnosis of PTSD
4. Age 18-65
Exclusion Criteria
2. History of significant neurological disease
3. Diagnosis of Schizophrenia or other Psychosis
4. Alcohol abuse/dependence or illicit drug use in the two weeks prior to testing
5. No history of combat service
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Eastern Colorado Health Care System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nazanin Bahraini, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
VA Eastern Colorado Healthcare System/MIRECC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Denver VA Medical Center
Denver, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10-0159
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.